21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
22 - Manufacture of rubber and plastic products
51.70.B - Transport lotniczy
60.24.B - Programming and broadcasting activities
74.40.Z - Other professional, scientific and technical activities
74.82.Z - Other professional, scientific and technical activities
74.84 - Other professional, scientific and technical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | 0,3 | 0,4 | 47,6 |
EBITDA | 0,7 | 0,5 | 0,6 | 25,5 |
Short time liabilities | 1,8 | 2,3 | 2,2 | -6,1 |
Equity capital | 0,7 | 0,8 | 1,1 | 43 |
Operating profit (EBIT) | 0,6 | 0,4 | 0,5 | 27,9 |
Assets | 3 | 3,4 | 3,7 | 9,5 |
Net profit (loss) | 0,4 | 0,2 | 0,3 | 52,5 |
Cash | 0,2 | 0,1 | 0,2 | 10,5 |
Liabilities and provisions for liabilities | 2,3 | 2,6 | 2,5 | -1 |
Net income from sale | 4,5 | 3,5 | 2,6 | -25,9 |
Working assets | 2,8 | 3,2 | 3,6 | 11,4 |
Depreciation | 0,1 | 0 | 0,1 | 4,5 |
% | % | % | p.p. | |
Profitability of capital | 55,6 | 28,2 | 30,1 | 1,9 |
Equity capital to total assets | 22 | 23,9 | 31,1 | 7,2 |
Gross profit margin | 9,1 | 7,7 | 15,3 | 7,6 |
EBITDA Margin | 14,8 | 13,4 | 22,6 | 9,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 144 | 245 | 310 | 65 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane